List of Excipients in API sildenafil citrate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing sildenafil citrate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| PFIZER LABORATORIES DIV PFIZER INC | REVATIO | sildenafil citrate | 0069-4190 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | |
| PFIZER LABORATORIES DIV PFIZER INC | REVATIO | sildenafil citrate | 0069-4190 | CELLULOSE, MICROCRYSTALLINE | |
| PFIZER LABORATORIES DIV PFIZER INC | REVATIO | sildenafil citrate | 0069-4190 | CROSCARMELLOSE SODIUM | |
| PFIZER LABORATORIES DIV PFIZER INC | REVATIO | sildenafil citrate | 0069-4190 | HYPROMELLOSE | |
| PFIZER LABORATORIES DIV PFIZER INC | REVATIO | sildenafil citrate | 0069-4190 | LACTOSE MONOHYDRATE | |
| PFIZER LABORATORIES DIV PFIZER INC | REVATIO | sildenafil citrate | 0069-4190 | MAGNESIUM STEARATE | |
| PFIZER LABORATORIES DIV PFIZER INC | REVATIO | sildenafil citrate | 0069-4190 | TITANIUM DIOXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing sildenafil citrate
Detailed excipient profiles for sildenafil citrate
Excipient focus: ACACIA
sildenafil citrate drug variants containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | sildenafil citrate | 70954-407 |
| >Company | >Ingredient | >NDC |
sildenafil citrate drug variants not containing ACACIA
Excipient focus: ALUMINUM OXIDE
sildenafil citrate drug variants containing ALUMINUM OXIDE
sildenafil citrate drug variants not containing ALUMINUM OXIDE
Excipient focus: ANHYDROUS CITRIC ACID
sildenafil citrate drug variants containing ANHYDROUS CITRIC ACID
sildenafil citrate drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
sildenafil citrate drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
sildenafil citrate drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
sildenafil citrate drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
sildenafil citrate drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: CARBOMER HOMOPOLYMER TYPE A
sildenafil citrate drug variants containing CARBOMER HOMOPOLYMER TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals (USA) Inc | sildenafil citrate | 70710-1716 |
| Zydus Lifesciences Limited | sildenafil citrate | 70771-1668 |
| >Company | >Ingredient | >NDC |
sildenafil citrate drug variants not containing CARBOMER HOMOPOLYMER TYPE A
Excipient focus: CELLULOSE, MICROCRYSTALLINE
sildenafil citrate drug variants containing CELLULOSE, MICROCRYSTALLINE
sildenafil citrate drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
sildenafil citrate drug variants containing CROSCARMELLOSE SODIUM
sildenafil citrate drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: DEXTROSE MONOHYDRATE
sildenafil citrate drug variants containing DEXTROSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Eugia US LLC | sildenafil citrate | 55150-166 |
| >Company | >Ingredient | >NDC |
sildenafil citrate drug variants not containing DEXTROSE MONOHYDRATE
Excipient focus: FD&C BLUE NO. 1
sildenafil citrate drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | sildenafil citrate | 70954-407 |
| >Company | >Ingredient | >NDC |
sildenafil citrate drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
sildenafil citrate drug variants containing FD&C BLUE NO. 2
sildenafil citrate drug variants not containing FD&C BLUE NO. 2
Excipient focus: GRAPE
sildenafil citrate drug variants containing GRAPE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | sildenafil citrate | 59651-420 |
| >Company | >Ingredient | >NDC |
sildenafil citrate drug variants not containing GRAPE
Excipient focus: HYPROMELLOSE
sildenafil citrate drug variants containing HYPROMELLOSE
sildenafil citrate drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
sildenafil citrate drug variants containing HYPROMELLOSE 2910
sildenafil citrate drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
sildenafil citrate drug variants containing HYPROMELLOSES
sildenafil citrate drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE
sildenafil citrate drug variants containing LACTOSE
sildenafil citrate drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
sildenafil citrate drug variants containing LACTOSE MONOHYDRATE
sildenafil citrate drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
sildenafil citrate drug variants containing MAGNESIUM STEARATE
sildenafil citrate drug variants not containing MAGNESIUM STEARATE
Excipient focus: MALTODEXTRIN
sildenafil citrate drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | sildenafil citrate | 59651-420 |
| >Company | >Ingredient | >NDC |
sildenafil citrate drug variants not containing MALTODEXTRIN
Excipient focus: POVIDONE K30
sildenafil citrate drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | sildenafil citrate | 70954-407 |
| >Company | >Ingredient | >NDC |
sildenafil citrate drug variants not containing POVIDONE K30
Excipient focus: SILICON DIOXIDE
sildenafil citrate drug variants containing SILICON DIOXIDE
sildenafil citrate drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BENZOATE
sildenafil citrate drug variants containing SODIUM BENZOATE
sildenafil citrate drug variants not containing SODIUM BENZOATE
Excipient focus: SODIUM STEARYL FUMARATE
sildenafil citrate drug variants containing SODIUM STEARYL FUMARATE
sildenafil citrate drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: SORBITOL
sildenafil citrate drug variants containing SORBITOL
sildenafil citrate drug variants not containing SORBITOL
Excipient focus: SUCRALOSE
sildenafil citrate drug variants containing SUCRALOSE
sildenafil citrate drug variants not containing SUCRALOSE
Excipient focus: TITANIUM DIOXIDE
sildenafil citrate drug variants containing TITANIUM DIOXIDE
sildenafil citrate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eugia US LLC | sildenafil citrate | 55150-166 |
| ANI Pharmaceuticals Inc | sildenafil citrate | 70954-407 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
sildenafil citrate drug variants containing TRIACETIN
sildenafil citrate drug variants not containing TRIACETIN
Excipient focus: TRISODIUM CITRATE DIHYDRATE
sildenafil citrate drug variants containing TRISODIUM CITRATE DIHYDRATE
sildenafil citrate drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
sildenafil citrate drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Eugia US LLC | sildenafil citrate | 55150-166 |
| >Company | >Ingredient | >NDC |
sildenafil citrate drug variants not containing WATER
Excipient focus: XANTHAN GUM
sildenafil citrate drug variants containing XANTHAN GUM
sildenafil citrate drug variants not containing XANTHAN GUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
